Brian G.M. Durie, MD, and 4 other renowned experts explore the changing landscape of the diagnosis of plasma cell disorders, including the differences between MGUS, smoldering myeloma, and active myeloma as well as the implications for risk stratification in early disease.
International myeloma experts—Brian G.M. Durie, MD; Shaji Kumar, MD; and Philippe Moreau, MD—discuss current treatment options for patients with newly diagnosed multiple myeloma and explore novel approaches now in clinical trials.
Jesús F. San-Miguel, MD, PhD, discusses current treatment options for patients with relapsed/refractory multiple myeloma and explores novel approaches now in clinical trials.